WS #15090
Corporate activity remains robust despite macro headwinds, with Snowflake successfully upsizing a $3.75 billion convertible note offering, indicating strong institutional appetite for its debt. In M&A news, SoundThinking shares jumped 50% following a takeover agreement, while Novo Nordisk secured a $2.6 billion licensing deal bolstered by positive cardiovascular data. These events highlight selective opportunities in biotech and tech debt markets even as broader equity valuations face pressure.
Corporate M&A and Capital Raising
Corporate activity remains robust despite macro headwinds, with Snowflake successfully upsizing a $3.75 billion convertible note offering, indicating strong institutional appetite for its debt. In M&A news, SoundThinking shares jumped 50% following a takeover agreement, while Novo Nordisk secured a $2.6 billion licensing deal bolstered by positive cardiovascular data. These events highlight selective opportunities in biotech and tech debt markets even as broader equity valuations face pressure.